455 related articles for article (PubMed ID: 28673244)
21. Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis.
Wang J; Liu Q; Shyr Y
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S5. PubMed ID: 26100984
[TBL] [Abstract][Full Text] [Related]
22. PR/SET Domain Family and Cancer: Novel Insights from the Cancer Genome Atlas.
Sorrentino A; Federico A; Rienzo M; Gazzerro P; Bifulco M; Ciccodicola A; Casamassimi A; Abbondanza C
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347759
[TBL] [Abstract][Full Text] [Related]
23. [Mutational tumor profiles beyond organ and tissue specificity: implications for diagnostics and clinical study design].
Klauschen F
Pathologe; 2014 Nov; 35 Suppl 2():277-80. PubMed ID: 25394977
[TBL] [Abstract][Full Text] [Related]
24. Thirty biologically interpretable clusters of transcription factors distinguish cancer type.
Abrams ZB; Zucker M; Wang M; Asiaee Taheri A; Abruzzo LV; Coombes KR
BMC Genomics; 2018 Oct; 19(1):738. PubMed ID: 30305013
[TBL] [Abstract][Full Text] [Related]
25. The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes.
Han L; Yuan Y; Zheng S; Yang Y; Li J; Edgerton ME; Diao L; Xu Y; Verhaak RGW; Liang H
Nat Commun; 2014 Jul; 5():3963. PubMed ID: 24999802
[TBL] [Abstract][Full Text] [Related]
26. The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical-genomic driver associations.
Lee H; Palm J; Grimes SM; Ji HP
Genome Med; 2015 Oct; 7():112. PubMed ID: 26507825
[TBL] [Abstract][Full Text] [Related]
27. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
Glinsky GV
Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
[TBL] [Abstract][Full Text] [Related]
28. The simple classification of multiple cancer types using a small number of significant genes.
Yang TY
Mol Diagn Ther; 2007; 11(4):265-75. PubMed ID: 17705581
[TBL] [Abstract][Full Text] [Related]
29. OMCD: OncomiR Cancer Database.
Sarver AL; Sarver AE; Yuan C; Subramanian S
BMC Cancer; 2018 Dec; 18(1):1223. PubMed ID: 30522456
[TBL] [Abstract][Full Text] [Related]
30. LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
Vasaikar SV; Straub P; Wang J; Zhang B
Nucleic Acids Res; 2018 Jan; 46(D1):D956-D963. PubMed ID: 29136207
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.
Snezhkina AV; Krasnov GS; Zaretsky AR; Zhavoronkov A; Nyushko KM; Moskalev AA; Karpova IY; Afremova AI; Lipatova AV; Kochetkov DV; Fedorova MS; Volchenko NN; Sadritdinova AF; Melnikova NV; Sidorov DV; Popov AY; Kalinin DV; Kaprin AD; Alekseev BY; Dmitriev AA; Kudryavtseva AV
BMC Genomics; 2016 Dec; 17(Suppl 14):1011. PubMed ID: 28105922
[TBL] [Abstract][Full Text] [Related]
32. Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers.
Mandel J; Avula R; Prochownik EV
BMC Cancer; 2020 Apr; 20(1):297. PubMed ID: 32264880
[TBL] [Abstract][Full Text] [Related]
33. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
[TBL] [Abstract][Full Text] [Related]
34. Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas.
Chen F; Zhang Y; Varambally S; Creighton CJ
Mol Cancer Res; 2019 Feb; 17(2):476-487. PubMed ID: 30401717
[TBL] [Abstract][Full Text] [Related]
35. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
[TBL] [Abstract][Full Text] [Related]
36. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
Zhao M; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
[TBL] [Abstract][Full Text] [Related]
37. Toward predicting metastatic progression of melanoma based on gene expression data.
Li Y; Krahn JM; Flake GP; Umbach DM; Li L
Pigment Cell Melanoma Res; 2015 Jul; 28(4):453-63. PubMed ID: 25847062
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients.
Yuan Y; Liu L; Chen H; Wang Y; Xu Y; Mao H; Li J; Mills GB; Shu Y; Li L; Liang H
Cancer Cell; 2016 May; 29(5):711-722. PubMed ID: 27165743
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.
Yu K; Chen B; Aran D; Charalel J; Yau C; Wolf DM; van 't Veer LJ; Butte AJ; Goldstein T; Sirota M
Nat Commun; 2019 Aug; 10(1):3574. PubMed ID: 31395879
[TBL] [Abstract][Full Text] [Related]
40. A Practical Guide to The Cancer Genome Atlas (TCGA).
Wang Z; Jensen MA; Zenklusen JC
Methods Mol Biol; 2016; 1418():111-41. PubMed ID: 27008012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
